Form 4 Filing for Gregory Russotti

Gregory Russotti, Chief Technology and Manufacturing Officer at Century Therapeutics, Inc., reported a transaction on June 8, 2026. The filing indicates the sale of 524 shares of Common Stock at a price of $2.111 per share. This transaction was executed to cover tax withholding obligations related to the vesting of restricted stock units. Following this transaction, Mr. Russotti has 514,903 shares directly owned. Additionally, 92,773 shares are held indirectly through the Gregory Russotti 2021 Family Trust. The sales were automatic and not at Mr. Russotti's discretion, as noted in the filing's remarks and footnotes.